BenevolentAI
BAI | XAMS
Overview
Corporate Details
- ISIN(s):
- LU2355630455
- LEI:
- 2221003P54KEDC3P4Z33
- Country:
- United Kingdom
- Address:
- 4-8 Maple Street, W1T 5HD London
- Website:
- https://www.benevolent.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
BenevolentAI is a leading clinical-stage artificial intelligence (AI) company specializing in drug discovery and development. Headquartered in London, BenevolentAI leverages cutting-edge AI and machine learning technologies to accelerate the identification of novel drug candidates, optimize clinical trial success, and address critical unmet medical needs. With its proprietary platform, the company integrates vast biomedical data with advanced computational techniques to uncover insights into disease mechanisms and therapeutic pathways. BenevolentAI collaborates with pharmaceutical and biotechnology partners worldwide, driving innovation to improve healthcare outcomes and advance the future of medicine.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-03-12 12:12 |
Delisting Announcement
BAI EGM Results APPROVED
|
English | 169.9 KB | |
| 2025-02-06 07:00 |
Inside Information Statement
Merger-Delisting and Notice of EGM FINAL APPROVED copy
|
English | 95.2 KB | |
| 2024-12-11 13:17 |
Delisting Announcement
BenevolentAI unveils major strategic overhaul with return to original mission
|
English | 440.5 KB | |
| 2024-12-11 07:00 |
Delisting Announcement
241211_BenevolentAI Statement_FINAL
|
English | 440.5 KB | |
| 2024-12-03 13:36 |
Declaration of Voting Results & Voting Rights Announcements
Regulatory Announcement - Issue of Equity and TVR (RSU Settlement) 03122024
|
English | 111.3 KB | |
| 2024-10-17 07:00 |
Board/Management Change
241017 BenevolentAI_Leadership update_Final
|
English | 384.6 KB | |
| 2024-09-23 14:15 |
Major Shareholding Notification
Major Shareholding Notification (LINK) - 13 September 2024 rev
|
English | 494.2 KB | |
| 2024-09-19 07:00 |
Earnings Release
240919_BAI Interims 24 press release_FINAL
|
English | 468.9 KB | |
| 2024-07-30 12:56 |
Directors' Dealings
PDMR Notification - Dr. Joerg Moeller
|
English | 56.6 KB | |
| 2024-07-03 07:00 |
Board/Management Change
BAI_LEADERSHIP TEAM CHANGE_FINAL_03.07.2024
|
English | 140.6 KB | |
| 2024-05-02 15:30 |
Declaration of Voting Results & Voting Rights Announcements
AGM Results 2 May 2024 FINAL
|
English | 129.2 KB | |
| 2024-05-01 12:37 |
Major Shareholding Notification
Major Holdings Notification (Annex A) ABG-ODY-BAI LIMITED
|
English | 62.7 KB | |
| 2024-04-23 07:00 |
Inside Information Statement
Business Update 23 April 24 FINAL
|
English | 166.2 KB | |
| 2024-04-17 07:00 |
Inside Information Statement
BAI_Publication of the Revised Agenda for the 2024 AGM_FINAL_17.04.24
|
English | 69.7 KB | |
| 2024-04-15 07:00 |
Declaration of Voting Results & Voting Rights Announcements
BAI_PROPOSED CHANGES TO BOARD COMPOSITION _FINAL_15.04.24
|
English | 168.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |